A Mendelian randomization study elucidates the causal relationship between sleep traits and glycemic control, highlighting the potential impact of sleep interventions on diabetes management and outcomes.
January 2023
Severe hypoglycemia is associated with an increased risk of QTc prolongation in individuals with type 2 diabetes, emphasizing the importance of glycemic management and monitoring to prevent adverse cardiac events in this population.
December 2022
Exercise induces the release of natural antioxidants and promotes angiogenesis, mitigating the damaging effects of diabetes on vascular health and providing insights into the therapeutic benefits of physical activity in diabetes management.
December 2022
Neither metformin nor lifestyle interventions reduce major cardiovascular events in the long term, despite their efficacy in preventing diabetes, highlighting the need for alternative strategies to mitigate cardiovascular risk in high-risk populations.
December 2022
Fatty liver disease is associated with various metabolic disorders, including type 2 diabetes and cardiovascular diseases, underscoring the importance of identifying predictive markers to facilitate early intervention and risk stratification.
December 2022
Insomnia is associated with an elevated risk of developing type 2 diabetes, suggesting the potential role of sleep disturbances in the pathogenesis of metabolic disorders and the importance of sleep interventions in diabetes prevention and management.
December 2022
Nocturnal exposure to light during sleep disrupts cardiometabolic function, leading to greater insulin resistance, elevated heart rate, and reduced heart rate variability upon waking, highlighting the importance of optimizing sleep environments to promote metabolic health.
November 2022
Frequent insomnia symptoms are associated with higher levels of glycated hemoglobin (HbA1c) in individuals with type 2 diabetes, suggesting a potential bidirectional relationship between sleep disturbances and glycemic control.
November 2022